SA
Shreyansh Agrawal
About Shreyansh Agrawal
Data last updated:
Shreyansh Agrawal is a Director at Futrans New Energy Vehicles Private Limited (since 2025), Designated Partner at Pathomate Diagnostics Llp (since 2024) and Designated Partner at Whitman Healthcare Llp (since 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Futrans New Energy Vehicles Private Limited U29100MP2025PTC078093 | Director | 02 Aug 2025 | 2025 | Active | |
| Pathomate Diagnostics Llp ACH-6522 | Designated Partner | 07 Jun 2024 | 2024 | Active | |
| Whitman Healthcare Llp ACH-2237 | Designated Partner | 17 May 2024 | 2024 | Active |
Board colleagues of Shreyansh Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manish Agarwal | 03616371 | Futrans New Energy Vehicles Private Limited , Pathomate Diagnostics Llp and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shreyansh Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shreyansh Agrawal
Shreyansh Agrawal currently holds 3 directorships: Futrans New Energy Vehicles Private Limited (Director, since 02 Aug 2025); Pathomate Diagnostics Llp (Designated Partner, since 07 Jun 2024); Whitman Healthcare Llp (Designated Partner, since 17 May 2024).
Shreyansh Agrawal was first appointed on 17 May 2024 as Designated Partner at Whitman Healthcare Llp. The most recent appointment on record is 02 Aug 2025 at Futrans New Energy Vehicles Private Limited.
The current boards of Shreyansh Agrawal's companies include Manish Agarwal (Futrans New Energy Vehicles Private Limited).